TechTalk: Interview with Alexander Dunaev, ID Finance
- 92
The Banker's Silvia Pavoni asks Alexander Dunaev, co-founder and COO of online lender ID Finance, about the company's expansion from Russia to Mexico and why it plans to focus its growth efforts...
The Banker

The Banker is the world's premier banking and finance resource. Read in over 180 countries around the world, The Banker is the key source of data and analysis for the industry. Its unique database of more than 4000 banks maps their financial strength and soundness via Tier 1 capital, their profitability, and their performance versus their peers.
The Banker has been providing global financial intelligence since 1926 and has built a reputation for objective and incisive reporting on major events. Every month the magazine combines in-depth regional and country coverage with reports on capital markets and structured finance, risk management, working capital management and securities services, environmental finance, trade and project finance, trading, technology and management and governance issues.
The Banker's senior editors travel the world to interview senior bankers and world leaders, giving the magazine a unique insight on global trends.
Lastest news
- Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system
- Johnson & Johnson's TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC
- Johnson & Johnson's TAR-200 monotherapy demonstrates highest complete response rate with sustained clinical benefits in patients with certain types of bladder cancer
- QUBT DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Quantum Computing Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 28 Deadline in Securities Class Action - QUBT
- Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer
- Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities